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Here,  we  conducted  in  vitro genotoxicity  tests  to  evaluate  the  genotoxicity  of styrene
oligomers  extracted  from  polystyrene  intended  for use  in contact  with  food.  Styrene
oligomers  were  extracted  with  acetone  and  the  extract  was  subjected  to  the  Ames  test
(OECD  test  guideline  No.  471)  and  the  in vitro  chromosomal  aberration  test  (OECD  test
guideline  No.  473)  under  good  laboratory  practice  conditions.  The  concentrations  of styrene
dimers and trimers  in  the concentrated  extract  were  540  and  13,431  ppm,  respectively.
Extraction  with acetone  provided  markedly  higher  concentrations  of  styrene  oligomers
compared  with  extraction  with 50%  ethanol  aqueous  solution,  which  is the  food  simulant
currently  recommended  for  use in  safety  assessments  of polystyrene  by  both  the  United
States  Food  and  Drug  Administration  and  the  European  Food  Safety  Authority.  And  these
high concentrations  of  styrene  dimers  and  trimers  were  utilized  for the  evaluation  of geno-
toxicity in  vitro.  Ames  tests  using  ﬁve  bacterial  tester  strains  were  negative  both  in  the
presence  or  absence  of  metabolic  activation.  The  in vitro  chromosomal  aberration  test
using  Chinese  hamster  lung  cells  (CHL/IU)  was  also  negative.  Together,  these  results  suggest
that the  risk of  the  genotoxicity  of  styrene  oligomers  that migrate  from  polystyrene  food
packaging  into  food  is very  low.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
the CC  BY  license  (http://creativecommons.org/licenses/by/3.0/).. IntroductionPolystyrene was ﬁrst used industrially in Germany in
he  mid-1930s, and since then, because of its useful charac-
eristics such as high processability, shape reproducibility,
Abbreviations: EFSA, European Food Safety Authority; GPPS, general
urpose polystyrene; FDA, United States Food and Drug Administration;
ECD, Organisation for Economic Co-operation and Development; SD,
tyrene dimer; ST, styrene trimer.
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http://creativecommons.org/licenses/by/3.0/).and superior foaming ability, it has been widely used in
the  production and packaging of commodities such as
electronic devices and food. It is estimated that in 2010
approximately 10.8 million tons of polystyrene was  used
worldwide [1]. In the developed world, 50–60% of the pro-
duction  volume of polystyrene is used for food packaging
[1,2]. Furthermore, polystyrene represents approximately
14% and 10% of plastic food-packaging materials used in the
United  States and Japan, respectively [3,4]. Polystyrene is
therefore  an important material for the packaging of food.Polystyrene products have been shown to contain
styrene oligomers, which were generated as byproducts
in the process of polymerization [5]. Concerns related to
the  human health effects of styrene dimers (SDs) and
 access article under the CC BY license
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Table 1
Gas  chromatography–mass spectrometry conditions for the determina-
tion of the styrene dimers and trimers present in the test solution.
GC/MS System Agilent 6890N/5973N gas
chromatograph (Agilent
Technologies,  CA, USA)
Column DB-WAX (0.25 mm × 30 m; ﬁlm
thickness, 0.25 m; Agilent
Technologies)
Column  temperature 100–250 ◦C at 20 ◦C/min, hold at
100 ◦C for 1 min, and 300 ◦C for
5  min
Injection temperature 250 ◦C
Interface temperature 250 ◦C
Ion source temperature 230 ◦C
Ionization voltage 70 eV
Ionization method Electronic ionization1176 M.  Nakai et al. / Toxicolo
styrene trimers (STs) have been raised by some inves-
tigators [6]. Kawamura reported that several kinds of
SDs  and STs can migrate from polystyrene products [7,8].
When  using 50% of ethanol aqueous solution, 30–70 ppb
of  styrene trimers were extracted and no styrene dimers
were  detected [7]. Under intact usage, although no styrene
dimers  were detected, the amount of the migrated styrene
trimers were estimated to be up to 33.8 g for one meal
[8].  The endocrine-disrupting potencies of SDs and STs
were  actively investigated in the late 1990s to early
2000s. Although there were some results indicating pos-
itive  responses in in vitro tests [9], the results based on
many  reliable studies including in vivo studies suggested
that SDs and STs do not have endocrine disrupting poten-
tial  [10–13]. For example, it was shown that SDs and STs
extracted from polystyrene with acetone cause no repro-
ductive toxicity in rats, either to dams or offspring, at
concentrations of up to 1.0 mg/kg/day, which is a concen-
tration 1000 times greater than the daily intake in humans
[13].
Prior  to new polymers being authorized for use in the
United States, the safety of extracted compounds, including
oligomers, must be assessed [3]. In the European Union, the
regulations  on plastic materials for food packaging were
revised  in 2011 [14], and when a new polymer is produced,
the  safety of unintentionally generated byproducts must
be  assessed. Thus, the safety of oligomers present in plastic
food  packaging is of great concern. Genotoxicity testing by
means  of the Ames test and the in vitro chromosomal aber-
ration  test are toxicological endpoints that are required by
both  the US Food and Drug Administration and the Euro-
pean  Food Safety Authority [15].
Despite the importance of the genotoxic effects of
styrene oligomers on human health, little information
is currently available. However, Grifoll et al. [16] did
report a negative Ames test for the genotoxicity of styrene
oligomers in Salmonella typhimurium strain TA98 under
conditions of metabolic activation.
Here, we evaluated the genotoxicity of styrene
oligomers extracted from polystyrene with acetone by
means  of the Ames test and the in vitro chromosomal aber-
ration  test.
2.  Materials and methods
2.1.  Materials
General purpose polystyrene (GPPS) pellets were sup-
plied  by Japan Styrene Industry Association (Tokyo, Japan).
The  molecular characteristics of GPPS pellets used in this
study  were as follows: The number-average and weight-
average molecular weights were 72,000 and 222,000,
respectively, and the concentration of SDs and STs in
the  GPPS pellets were 0.16% (w/w) and 1.02% (w/w),
respectively. S. typhimurium strains TA100, TA1535, TA98,
and  TA1537, and Escherichia coli strain WP2uvrA  were
purchased from National Institute of Technology and Eval-
uation  (Tokyo, Japan). Chinese hamster lung ﬁbroblasts
(CHL/IU) were purchased from Health Science Research
Resources Bank, Japan Health Sciences Foundation (Tokyo,
Japan).  S9 prepared from the livers of seven-week-oldInjection mode Splitless
Injection  volume 2 L
Carrier gas Helium
male Sprague-Dawley rats administered phenobarbital and
5,6-benzoﬂavone was purchased from Oriental Yeast Co.
(Tokyo,  Japan). All reagents were of the best grade available.
2.2.  Methods
2.2.1. Preparation of test samples
The test solution used in the genotoxicity tests was
produced as follows: GPPS pellets (120 g) were added to
600  mL  of acetone and the mixture was  stirred with a
Teﬂon-coated stir bar for 1 h at 40 ◦C. The solution was then
mixed  with 2.4 L of methanol, stirred for 1 h at room tem-
perature, and then ﬁltered through No. 2 ﬁlter paper (Toyo
Roshi,  Tokyo, Japan). The ﬁltrate was evaporated (bath tem-
perature,  approx. 40 ◦C) and the residue was dissolved in
acetone  to prepare 20 mL  of acetone solution. This concen-
trated solution was then used as the test solution in the
genotoxicity tests and was  considered to have a purity of
100%.
The  concentrations of SDs and STs in the test solution
were determined by means of gas chromatography–mass
spectrometry. The analytical conditions are shown in
Table  1.
The  molecular weight distribution of the test sample
was  determined by means of gel permeation chromatog-
raphy. The analytical conditions are shown in Table 2.
One  milliliter of test sample was dried under a nitrogen
gas purge and the residue was  then dissolved in tetrahy-
drofuran to make 10 mL  of tetrahydrofuran solution. The
tetrahydrofuran solution was kept at 25 ◦C for approxi-
mately 24 h before use.
2.2.2. Ames test
The  Ames test was conducted according to the Organisa-
tion for Economic Co-operation and Development (OECD)
Guideline for the Testing of Chemicals, No. 471, Bacterial
Reverse Mutation Test [17], as follows.2.2.2.1. Chemical treatment and colony counting. A pre-
incubation method in the presence or absence of S9 mix
was  used [18]. Triplicate plates were used for each dose.
S.  typhimurium strains TA100, TA1535, TA98, and TA1537
M. Nakai et al. / Toxicology Repo
Table 2
High-performance liquid chromatography conditions for the determina-
tion of the molecular weight distribution of the test solution.
Instruments
GPC system GPC-101 (Showa Denko K.K.,
Tokyo, Japan)
Detector Refractive Index Detector (Showa
Denko K.K.)
Data treatment system Shodex 480 II (Showa Denko K.K.)
Column
Shodex GPC KF-806 L × 2
(8.0 mm × 300 mm,  Showa Denko
K.K.)
Shodex GPC KF-800D × 1
(8.0  mm × 100 mm,  Showa Denko
K.K.)
Column  temperature 40 ◦C
Eluent Tetrahydrofuran
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A total of four SDs and ﬁve STs were detected in the test
sample (Table 3 and Fig. 1). The total SD and ST content
of the test sample was  approximately 88%; approximately
Table 3
Concentrations of styrene dimers and trimers detected in the test sample.
Compound name Concentration
(ppm)
Total
concentration
(ppm)
Styrene dimer
1,3-Diphenylpropane
(SD-1)
8
540cis-1,2-
Diphenylcyclobutane
(SD-2)
77
2,4-Diphenyl-1-butene
(SD-3)
84
trans-1,2-
Diphenylcyclobutane
(SD-4)
371
Styrene trimer
2,4,6-Triphenyl-1-
hexene
(ST-1)
1649
13,431
1e-Phenyl-4e-(1′-
phenylethyl)tetralin
(ST-2)
3078
1a-Phenyl-4e-(1′-
phenylethyl)tetralin
(ST-3)
4821
1a-Phenyl-4a-(1′-
phenylethyl)tetralin
2114Flow  rate 0.8 mL/min
Injection volume 100 L
PC, gel permeation chromatography.
nd E. coli strain WP2uvrA  were used as the bacterial
ester strains. The test solution was diluted with acetone
o  prepare the test doses. The maximum concentration of
he  test doses was 10% (w/v). The test sample formulation
as mixed with the bacterial culture in the presence or
bsence  of S9 mix  and pre-incubated at 37 ◦C for 20 min.
oft  agar was added to the mixture, which was then poured
nto  a minimal glucose agar plate (Tesmedia AN; Oriental
east  Co., Tokyo, Japan). Triplicate plates were used for each
ose.  The ﬁnal concentration of S9 in the top agar layer was
%.  After incubation at 37 ◦C for 48 h, the number of rever-
ant  colonies was counted by using a colony counter system
CA-11D; System Sciences, Tokyo, Japan). Precipitation of
he  test sample and inhibition of bacterial growth were also
hecked  macroscopically. To conﬁrm the reproducibility of
he  test results, two independent tests were conducted.
.2.2.2. Evaluation of results. The Ames test was consid-
red positive when the number of revertant colonies was
ncreased to two or more times that of the negative control
nd  when the response was dose-related or reproducible,
r both. All other cases were considered negative. No sta-
istical  methods were used.
.2.3. In vitro chromosomal aberration test
The in vitro chromosomal aberration test was conducted
ccording to OECD Guideline for the Testing of Chemicals,
o. 473, In Vitro Mammalian Chromosome Aberration Test
19],  as follows.
.2.3.1. Chemical treatment, slide preparation, and assess-
ent. The procedure reported by Ishidate and Odashima
20] was followed. CHL/IU cells were pre-cultured in
0%  (v/v) heat-inactivated newborn calf serum/minimum
ssential medium in CO2 incubator (MCO-18AIC, SANYO
lectric, Osaka, Japan), which was set at 37 ◦C and an atmo-
phere of 5% CO2 under a humid condition. Duplicate dishes
ere  used for each dose. The test solution was diluted with
cetone  to prepare the test doses. The maximum concen-
ration of the test dose was 50% (w/v). Cells were treated
ith  medium containing 1% (v/v) of the test sample formu-
ation.  For short-term treatment, cells were treated for 6 hrts 1 (2014) 1175–1180 1177
at  37 ◦C in the presence or absence of 5% S9, after which,
the medium was discarded, and the cells were rinsed with
PBS(−)  and cultured for another 18 h at 37 ◦C in fresh
medium. For continuous treatment, cells were treated for
24  h in the absence of metabolic activation. At the start
and  end of the treatment period, and at the end of cul-
turing, whether or not the test sample had precipitated
was checked macroscopically. At the end of culturing, the
number  of cells was  counted by using a Microcell counter
(CDA-500; Sysmex, Hyogo, Japan) after trypsinization, and
the  cell growth rate at each dose was  calculated. Finally,
the  prepared specimens were stained with Giemsa solution
(Merck, Darmstadt, Germany) and 200 metaphase cells per
dose  were evaluated for structural aberrations and numer-
ical  aberrations, respectively.
2.2.3.2.  Evaluation of results. The in vitro chromosomal
aberration test was considered positive when the fre-
quency of cells with structural aberrations or numerically
aberrant cells was 10% or more and the increase was
dose-related. All other cases were considered negative. No
statistical  analyses were used.
3. Results
3.1. Analysis of SDs and STs in the test sample(ST-4)
1e-Phenyl-4a-(1′-
phenylethyl)tetralin
(ST-5)
1769
1178 M.  Nakai et al. / Toxicology Reports 1 (2014) 1175–1180
SD-4SD-3SD-2SD-1
ST-3 
 test samST-2 ST-1 
Fig. 1. Chemical structures of styrene dimers and trimers detected in the
12% of the styrene oligomers in the test sample were of
tetrameric or greater size (data not shown).
3.2. Ames test
Prior  to conducting the Ames test, a dose range-ﬁnding
study was conducted using six doses: 156, 313, 625, 1250,
2500,  and 5000 g/plate. No increase in the number of
revertant colonies and no bacterial growth inhibition were
observed  at any of the doses examined (data not shown).
Therefore, the same six doses were used for the ﬁrst
Ames test. To conﬁrm the reproducibility of the results, a
second  Ames test was conducted, but this time in consid-
eration of the results of the ﬁrst test, only ﬁve doses were
used:  313, 625, 1250, 2500, and 5000 g/plate. Because the
dose–response curves obtained from the two Ames tests
were  comparable, only the dose–response curves from the
ﬁrst  test are presented (Fig. 2).
The number of revertant colonies in each dose was  sim-
ilar  to that in the negative control for all tester strains. No
inhibition of bacterial growth and no precipitation of the
test  substance were observed for any of the test condi-
tions in either the presence or absence of S9 mix. Therefore,
because the number of revertant colonies in all treatment
(A)  
0
20
40
60
80
100
120
140
160
180
5000250012506253131560
N
um
be
r 
of
 re
ve
rt
an
t 
co
lo
ni
es
 
pe
r p
la
te
Test sample dose (μ g/ plate)
Fig. 2. Dose–response curves in the Ames test in the absence (A) or presence (B
strain TA1535; , S. typhimurium strain TA98; , S. typhimurium strain TA1537; ×ST-5 ST-4 
ple. Abbreviated names of each compound were designated in Table 3.
groups for all tester strains was  less than twice that in each
negative control in the presence or absence of S9 mix  in
both  the ﬁrst and second Ames test, the genotoxicity of the
test  solution was considered negative.
The numbers of revertant colonies in the negative con-
trol  and positive control were within the historical range
for  our laboratory (data not shown).
3.3. In vitro chromosomal aberration test
Prior to the in vitro chromosomal aberration test, a dose
range-ﬁnding study was  conducted using nine concen-
trations: 19.5, 39.1, 78.1, 156, 313, 625, 1250, 2500, and
5000  g/mL. No cytotoxicity was observed at any concen-
tration under any condition, but precipitation of the test
substance was observed at concentrations of 1250 g/mL
or  greater. Therefore, only concentrations of 1250, 2500,
and  5000 g/mL were used in the in vitro chromosomal
aberration test.
Relative  cell growth rate was  greater than 68% and
no  cytotoxicity was detected for all concentrations at
all  treatment conditions (Table 4). Precipitation of the
test  substance was  detected at all three doses examined.
The percentages of cells with structural aberrations or
(B) 
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) of S9 mix. ©, Salmonella typhimurium strain TA100; , S. typhimurium
, Escherichia coli strain WP2uvrA.
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Table 4
Results of the in vitro chromosomal aberration test.
Treatment
condition
Test  sample dose (g/mL) Precipitation
from mediuma
Relative cell growth rate (%) Frequency of cells with aberrations (%)
Structural
aberration
Numerical
aberration
Absence of S9 mix
(6-h  treatment)
0 – 100 2.5 1.0
1250 + 92.6 0.0 0.0
2500 + 88.3 2.5 0.0
5000 + 82.9 0.5 0.0
Presence  of S9 mix
(6-h  treatment)
0 − 100 1.0 0.0
1250 + 93.3 1.0 0.0
2500 + 83.8 2.5 1.0
5000 + 72.7 0.5 0.5
Continuous
method  (24-h
treatment)
0  − 100 1.5 0.0
1250 + 87.6 0.5 0.0
2500 + 79.6 1.0  0.0
68.2 1.0 0.0
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Table 5
Reported concentrations of styrene oligomers extracted from polystyrene
food packaging with various simulants.
Extraction conditions Concentration of styrene oligomer (ppb)
Water, 95 ◦C, 30 min  NDa,b NDc 0.04–4.0d
20% Ethanol, 60 ◦C,
30 min
5–10b NDc 1.4–10.3d
50% Ethanol, 60 ◦C,
30 min
30–70b ND–15.7c –
a 60 ◦C, 30 min.5000 + 
a Precipitation: − absence; + presence.
umerically aberrant cells were below 3% at all concentra-
ions and for all treatment conditions; therefore, the in vitro
hromosomal aberration test was considered negative for
oth  structural and numerical aberrations.The frequencies
f  cells with structural aberrations in the negative and pos-
tive  controls, and the frequencies of numerically aberrant
ells  in the negative control, were all within the historical
ange for our laboratory (data not shown).
. Discussion
There are few reports in the literature presenting eval-
ations of the genotoxicity of styrene oligomers. Grifoll
t  al. [16] reported a negative Ames test; however, their
tudy  examined only one tester strain (S. typhimurium
train TA98) under conditions of metabolic activation by
he  microsomal fraction of the livers of male Sprague-
awley rats induced with Aroclor® 1254. Therefore, the
otential for extrapolating those results to determine the
enotoxic effects of styrene oligomers on human health
s  limited. Thus, to contribute to the risk assessment of
tyrene  oligomers migrated from polystyrene food pack-
ging  into food, in the present study we carried out the
enotoxicity tests required by the FDA and EFSA for the
afety  evaluation of food packaging by using a concentrated
olution of oligomers extracted from polystyrene intended
or  use in contact with food.
The migration of SDs and STs from polystyrene food
ackaging to food was investigated by Kawamura et al.
7,8]  and Nakada et al. [21]. The migration of SDs and STs to
oods  such as instant noodles under general use conditions
as  been investigated and compared with the concentra-
ions of SDs and STs extracted with organic solvents [8]. The
igration  of SDs and STs to food can be as high as approxi-
ately 50 ppb [21], whereas the concentrations of SDs and
Ts  extracted with 50% ethanol solution can be as high as
0  ppb (Table 5; [7,8,21]). The FDA recommends using 50%
thanol  as a high-fat food simulant when examining the
afety  of polystyrene [3] and the EFSA recommends as milk
roducts  out of high-fat food simulant [15].b Kawamura et al. [7], ND < 5 ppb.
c Kawamura et al. [8], ND < 1 ppb.
d Nakada et al. [21].
Reproductive toxicity testing in rats has shown that
the extraction of SDs and STs from polystyrene with ace-
tone  allows rats to be exposed to doses of SDs and STs
that  are comparable to the daily intake in humans [13].
Therefore, in the present study, we also used acetone as
the  extraction solvent. However, this procedure might be
given  to leading an overestimation of the risk because it
was  expected that acetone had greater extraction capac-
ity  compared to the authentic simulant which represents
the migration of styrene oligomers from polystyrene into
food  in general use. In this context, regardless of what the
genotoxicity tests result in positive or negative, we can
obtain  the highest doses, at which the genotoxic responses
become equivalent to the spontaneous levels. Then, to
avoid  overemphasis of the risk, we  can compare these doses
and  the concentration of the styrene oligomers extracted
by  simulant and this comparison considering a margin
of  extraction amount would give us valuable insight to
assess  the risk of the styrene oligomers extracted from
polystyrene.
Compared with 50% ethanol, acetone clearly had a
greater capacity to extract SDs and STs. The concentra-
tions of SDs and STs in the test solution were 540 ppm
and 13,431 ppm, respectively (total, 13,971 ppm), whereas
the  maximum total concentration of SDs and STs that can
be  extracted from polystyrene with 50% ethanol solution
is  70 ppb [7]. Therefore, the total concentration of SDs
and  STs extracted with acetone in the test solution was
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approximately 200,000 times higher than that extracted
with 50% ethanol solution. This result shows that the
capacities of solvents to extract styrene oligomers from
polystyrene are inﬂuenced by the polarity of each sol-
vent.  Water, which possesses the highest polarity among
solvents listed in Table 5, showed the lowest capacity to
extract  styrene oligomers. On the other hand, regarding the
pattern  of compounds extracted from the polystyrene, the
ratio  of SDs to STs became greater when the polarity of the
solvent  became higher [21].
In addition, the ratio of SDs to STs in the test solution
used in the present study was not so different from that in
the  GPPS pellets themselves, showing that acetone extrac-
tion  allowed cells to be exposed to test samples containing
a  sufﬁciently high concentration of SDs and STs in a similar
ratio  to that found in the original GPPS pellets.
Both the Ames test and the in vitro chromosomal aberra-
tion  test, which are the tests required by the FDA and EFSA
for  the safety evaluation of food packaging, were negative
even  when high concentrations of oligomers were used
compared to the case of fatty-food simulant, suggesting
that the risk of genotoxicity of styrene oligomers migrated
from  polystyrene food packaging into food is very low.
Our  results also provide useful data on the clastogenic
and polyploidy-inducing potential of styrene oligomers.
Because of the low solubility of styrene oligomers in aque-
ous  condition, it was expected that the mixture of styrene
oligomers would precipitate out of the culture medium
during the in vitro chromosomal aberration test, which
indeed occurred at doses of 1250 g/mL or greater. As
stated  in OECD Guideline for the Testing of Chemicals, No.
473,  regarding exposure conditions, doses with precipi-
tation but no cytotoxicity should be used as the highest
dose in the in vitro chromosomal aberration test. In the
present study, all three concentrations assessed resulted
in  precipitation of the styrene oligomers out of the culture
medium, conﬁrming that the concentration of oligomers
used in the present study contained high concentrations
of styrene oligomers. In addition, there was no cytotoxic-
ity  at the three doses assessed. It is likely that the present
results obtained by using an extracted solution of styrene
oligomers are comparable to those that would be obtained
by  using a pure oligomer solution.
5. Conclusion
Our ﬁndings show the availability of acetone instead
of 50% ethanol aqueous solution, which is recommended
as a fatty-food simulant for polystyrene by FDA and EFSA,
to  extract styrene oligomers from polystyrene intended
for  use in contact with food to allow the evaluation of
genotoxicity in vitro. Even if high concentrations were
applied the Ames test and the chromosomal aberration test,
styrene  oligomers extracted from GPPS did not induce gene
mutation  nor chromosomal aberration, suggesting that the
risk  of the genotoxicity of styrene oligomers migrated
from polystyrene food packaging into food is likely very
low.
[rts 1 (2014) 1175–1180
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